Daniel Corey
Director Ejecutivo en CERo Therapeutics, Inc. .
Fortuna: 946 773 $ al 30/04/2024
Perfil
Daniel Mark Corey is the founder of CERo Therapeutics, Inc. which was founded in 2018.
He holds the title of Chief Executive & Technology Officer at CERo Therapeutics, Inc. Currently, Dr. Corey is the Director & Chief Technical Officer at CERo Therapeutics Holdings, Inc. since 2021.
Dr. Corey's education includes an undergraduate degree from Brown University and a doctorate degree from UW Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4.56% | 05/04/2024 | 671 470 ( 4.56% ) | 946 773 $ | 30/04/2024 |
Cargos activos de Daniel Corey
| Empresas | Cargo | Inicio |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director Ejecutivo | 01/01/2018 |
Formación de Daniel Corey.
| Brown University | Undergraduate Degree |
| UW Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Corey